Drug Shortage Report for MANNITOL INJECTION USP
Report ID | 76861 |
Drug Identification Number | 00038024 |
Brand name | MANNITOL INJECTION USP |
Common or Proper name | Mannitol Injection USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MANNITOL |
Strength(s) | 250MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 25 x 50mL GVL |
ATC code | B05BC |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-07-02 |
Estimated end date | |
Actual end date | 2020-04-21 |
Shortage status | Resolved |
Updated date | 2020-04-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v29 | 2020-04-22 | English | Compare |
v28 | 2020-04-21 | French | Compare |
v27 | 2020-04-21 | English | Compare |
v26 | 2020-04-21 | French | Compare |
v25 | 2020-04-21 | English | Compare |
v24 | 2020-04-15 | French | Compare |
v23 | 2020-04-15 | English | Compare |
v22 | 2020-02-12 | French | Compare |
v21 | 2020-02-12 | English | Compare |
v20 | 2020-01-22 | French | Compare |
v19 | 2020-01-22 | English | Compare |
v18 | 2019-11-08 | French | Compare |
v17 | 2019-11-08 | English | Compare |
v16 | 2019-08-26 | French | Compare |
v15 | 2019-08-26 | English | Compare |
v14 | 2019-07-03 | French | Compare |
v13 | 2019-07-03 | English | Compare |
v12 | 2019-07-03 | English | Compare |
v11 | 2019-05-26 | English | Compare |
v10 | 2019-05-17 | French | Compare |